Sorrento Therapeutics Inc (SRNE)

[dia76ca]

The shorters enjoy attacking small biotechs on days when the entire market is down. They want to take cheap shares from weak hands! It is a good time for intelligent investors to load up. And why is Sorrento a good choice?
NAME ANOTHER SMALL BIOTECH WITH....
1. over 60 drug programs
2. potential blockbusters in Covid, cancer and non-opioid pain, and
3. a strong financial base. Sorrento has invested wisely and has 8.2 million shares of ImmunityBio, 20+ million shares of Celularity and 35% of ImmuneOncia. These are worth many hundreds of millions and the PSS lawsuit will soon be settled with very large potential gains. And it has many attractive programs to partner for upfront, milestone and royalty payments! Huge portfolio AND huge assets! And after the $34 million DARPA grant look for more to fund the battle against viral variants!
I love the smell of a short squeeze in the morning!